Processa Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,424 | -2,809 | ||
EBITDA | -3,384 | -3,081 | -2,809 | -2,469 |
EBIT | -3,384 | -3,082 | -2,809 | -2,469 |
Net Income | -3,384 | -3,010 | -2,726 | -2,404 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,605 | -3,345 | -2,048 | -2,123 |
Cash | 2,891 | 5,571 | 8,920 | 4,706 |
Basic Shares | 3,275 | 2,983 | 2,466 | 1,889 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -27,525 | -12,133 | -15,136 | |
EBITDA | -11,456 | -19,468 | -11,082 | -5,633 |
EBIT | -11,457 | -20,342 | -11,957 | -6,515 |
Net Income | -11,121 | -54,848 | -11,427 | -14,413 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 14,724 | |||
Free Cash Flow | -8,066 | -9,605 | -8,717 | -3,143 |
Cash | 4,706 | 6,503 | 16,497 | 15,416 |
Basic Shares | 1,311 | 805 | 765 | 374 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.03 |
2024-06-30 | -$1.01 |
2024-03-31 | -$1.11 |
2023-12-31 | -$1.70 |
